Servier takes pride in its commitment to Research and Development. Our investment in R&D is dedicated to delivering meaningful innovation for patients while conducting all phases of R&D according to the highest ethical standards.A proportion of this research is done through clinical trials

Servier conducts clinical trials for its products through a number of therapeutic research centres all over the world.  Servier Research and Development (SRDL) is currently involved in a number of trials in several therapeutic areas including leukaemia, lymphoma, colorectal cancer as well as in neuropsychiatry.

Servier’s interventional clinical trials are registered on these registries:


Servier is dedicated to supporting research that helps advance medical and scientific knowledge. As part of our commitment to research we recognise the valuable role of investigator initiated trials (IITs).  IITs are clinical studies initiated and managed by non-pharmaceutical company researchers e.g. individual researchers, institutions or collaborative study groups.

Servier may be able to support such studies by providing grant funding, and/or drug supply depending on the type of research. 

If you are from the UK and are interested in discussing research questions or submitting your ideas, email us at

Please note that proposals are reviewed based on their scientific merit, research priorities, and available resources. Submission of a request does not guarantee approval.